Table 2.
Resistance of Acinetobacter baumannii to 12 antibiotics according to site of infection (n, %)
| Antimicrobial drug | Blood (7) | Lung (8) | Intra-abdominal/biliary duct (8) | Urinary tract (1) | Cases of total drug resistance (n) |
|---|---|---|---|---|---|
| MEM | 3 (42.9) | 8 (100) | 6 (75) | 1 (100) | 18 (75) |
| TZP | 3 (42.9) | 8 (100) | 6 (75) | 1 (100) | 18 (75) |
| CAZ | 4 (57.1) | 7 (87.5) | 6 (75) | 1 (100) | 18 (75) |
| FEP | 3 (42.9) | 8 (100) | 6 (75) | 1 (100) | 18 (75) |
| CXM | 4 (57.1) | 8 (100) | 7 (87.5) | 1 (100) | 20 (83.3) |
| CZO | 5 (71.4) | 8 (100) | 7 (87.5) | 1 (100) | 21 (87.5) |
| AN | 5 (71.4) | 6 (75) | 4 (50) | 1 (100) | 16 (66.7) |
| LVF | 3 (42.9) | 5 (62.5) | 6 (75) | 1 (100) | 15 (62.5) |
| TGC | 0 (0) | 0 (0) | 1 (12.5) | 0 (0) | 1 (4.2) |
| SXT | 3 (42.9) | 7 (87.5) | 5 (62.5) | 1 (100) | 16 (66.7) |
| CFS | 1 (14.3) | 6 (75) | 4 (50) | 0 (0) | 11 (45.8) |
| ATM | 4 (57.1) | 8 (100) | 6 (75) | 1 (100) | 19 (79.2) |
Abbreviations: MEM, meropenem; TZP, piperacillin-tazobactam; CAZ, ceftazidime; FEP, cefepime; CXM, cefuroxime; CZO, cefazolin; AN, amikacin; LVF, levofloxacin; TGC, tigecycline; SXT, trimethoprim-sulfamethoxazole; CFS, cefoperazone-sulbactam; ATM, aztreonam.